Literature DB >> 11741927

The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.

Dianbo Qu1, Qing Li, Hui-Ying Lim, Nam Sang Cheung, Rong Li, Jerry H Wang, Robert Z Qi.   

Abstract

The neuronal Cdk5 kinase is composed of the catalytic subunit Cdk5 and the activator protein p35(nck5a) or its isoform, p39(nck5ai). To identify novel p35(nck5a)- and p39(nck5ai)-binding proteins, fragments of p35(nck5a) and p39(nck5ai) were utilized in affinity isolation of binding proteins from rat brain homogenates, and the isolated proteins were identified using mass spectrometry. With this approach, the nuclear protein SET was shown to interact with the N-terminal regions of p35(nck5a) and p39(nck5ai). Our detailed characterization showed that the SET protein formed a complex with Cdk5/p35(nck5a) through its binding to p35(nck5a). The p35(nck5a)-interacting region was mapped to a predicted alpha-helix in SET. When cotransfected into COS-7 cells, SET and p35(nck5a) displayed overlapping intracellular distribution in the nucleus. The nuclear co-localization was corroborated by immunostaining data of endogenous SET and Cdk5/p35(nck5a) from cultured cortical neurons. Finally, we demonstrated that the activity of Cdk5/p35(nck5a), but not that of Cdk5/p25(nck5a), was enhanced upon binding to the SET protein. The tail region of SET, which is rich in acidic residues, is required for the stimulatory effect on Cdk5/p35(nck5a).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741927     DOI: 10.1074/jbc.M107270200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.

Authors:  Ya-Li Zheng; Niranjana D Amin; Ya-Fang Hu; Parvathi Rudrabhatla; Varsha Shukla; Jyotshnabala Kanungo; Sashi Kesavapany; Philip Grant; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

2.  The proto-oncogene SET interacts with muscarinic receptors and attenuates receptor signaling.

Authors:  Violaine Simon; Jessie Guidry; Thomas W Gettys; Andrew B Tobin; Stephen M Lanier
Journal:  J Biol Chem       Date:  2006-10-25       Impact factor: 5.157

3.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

4.  The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death.

Authors:  En Huang; Dianbo Qu; Yi Zhang; Katerina Venderova; M Emdadul Haque; Maxime W C Rousseaux; Ruth S Slack; John M Woulfe; David S Park
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

5.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

6.  Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.

Authors:  Lisette Arnaud; She Chen; Fei Liu; Bin Li; Sabiha Khatoon; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  FEBS Lett       Date:  2011-07-28       Impact factor: 4.124

7.  Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex.

Authors:  Eric Lam; Tej K Pareek; John J Letterio
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

Authors:  Jie Zhang; Huifang Li; Odessa Yabut; Haley Fitzpatrick; Gabriella D'Arcangelo; Karl Herrup
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

9.  Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.

Authors:  Steve D Haenchen; Jeff A Utter; Adam M Bayless; Rick T Dobrowsky; David J Davido
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

10.  NF-protocadherin and TAF1 regulate retinal axon initiation and elongation in vivo.

Authors:  Michael Piper; Asha Dwivedy; Louis Leung; Roger S Bradley; Christine E Holt
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.